Hearing Disorders: Clinical Trials

1,763 trials for Hearing Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

914 completed, 266 unknown, 229 recruiting, 117 not yet recruiting. 1057 Not applicable, 152 Phase 2, 78 Phase 1, 59 Phase 3, 35 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1057Completed 582, Recruiting 140, Unknown 137, Not yet recruiting 61, Terminated 47, Withdrawn 44, Active not recruiting 25, Enrolling by invitation 18, Suspended 3
Phase 2152Completed 79, Unknown 16, Recruiting 15, Not yet recruiting 13, Terminated 12, Active not recruiting 7, Withdrawn 7, Enrolling by invitation 2, Suspended 1
Phase 178Completed 39, Recruiting 10, Unknown 8, Terminated 7, Not yet recruiting 6, Withdrawn 5, Active not recruiting 2, Suspended 1
Phase 359Completed 25, Terminated 11, Recruiting 8, Not yet recruiting 5, Unknown 5, Active not recruiting 3, Suspended 1, Withdrawn 1
Phase 435Completed 15, Unknown 8, Not yet recruiting 3, Recruiting 3, Active not recruiting 2, Terminated 2, Withdrawn 2
Early Phase 115Completed 7, Unknown 3, Recruiting 2, Enrolling by invitation 1, Not yet recruiting 1, Terminated 1

Follow Hearing Disorders: new trials by email Literature Review of Hearing Disorders trials Research Report on Hearing Disorders

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Role of Exposure in Hyperacusis
Psychoeducation - Hyperacusis
Not applicableNot yet recruitingUniversity Hospital, Antwerp52027-12-072026-04-29
First In Human Randomised Trial of Rincell-1 in Adults With a Cochlear Implant
Otic neural progenitors, cochlear implantation - Sensorineural Hearing Loss, Presbyacusis
Phase 1 / Phase 2Not yet recruitingRinri Therapeutics202027-09-012026-10-01
Hearing Loss and Brain Health Study
Over-The-Counter (OTC) hearing aid - Hearing Loss, Adult-Onset, Dementia
Not applicableNot yet recruitingUniversity of Southern California402027-07-012026-05-08
Microtable® Method for Cochlear Implantation Investigational Device Exemption (IDE)
The Microtable® Stereotactic System - Hearing Loss, Cochlear
Not applicableNot yet recruitingMedical University of South Carolina122027-07-012026-06-18
Cochlear Implantation and Social Outcomes
Cochlear implant - Hearing Loss, Bilateral Sensorineural
Not yet recruitingUniversity of Southern California402027-07-012026-06-22
Intervention for Hearing Health Among Native Americans
Talking Circle, Diabetes prevention program & delayed TC - Noise-Induced Hearing Loss
Not applicableNot yet recruitingUniversity of California, San Francisco4002027-04-012026-08-21
Maximizing Quality of Life After Cancer Through Rehabilitation
TIMELY REHAB - Head and Neck Cancer, Hearing Loss
Not applicableNot yet recruitingVA Office of Research and Development742027-03-012026-06-03
From Early Music Audiometry to Tone Audiograms
Soundfield Behavioral Audiometry - Hearing Loss, Audiometric Tests
Not yet recruitingGuy's and St Thomas' NHS Foundation Trust1002027-03-012026-07-24
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Auditory-Cognitive Optimization Care Program for Older Adults With Hearing Loss and Cognitive Impairment
Auditory-Cognitive Optimization Care Program (A-COP), Hearing Management and Newspaper-Reading Activities - Hearing Loss, Cognitive Impairment
Not applicableNot yet recruitingTaipei Medical University762027-02-012026-10-13
A Study Testing Safety and Efficacy of Transtympanic Paliroden for the Treatment of Cochlear Synaptopathy in Participants With Chronic, Constant Tinnitus
paliroden (CIL001), Placebo - Tinnitus, Bilateral, Cochlear Synaptopathy
Phase 1 / Phase 2Not yet recruitingCilcare SAS602027-01-012026-09-17
Multimodal Therapy for Somatosensory Tinnitus
Multimodal physiotherapy for TMJ and Cervical spine, Combined Exercise Program (Aerobic + Resistance + Breathing), Tinnitus-Specific Psychological Support - Ear Noise, Tinnitus, Noise Induced
Not applicableNot yet recruitingCharles University, Czech Republic1602027-01-012026-03-12
The Hear Clear Study
Signal-to-Noise Ratio Enhancement (SNR+), Signal-to-Noise Ratio Neutral (SNR-) - Hearing Loss
Not applicableNot yet recruitingDuke University1252027-01-012026-09-21
Advanced Neurofeedback for Tinnitus
Neurofeedback - Tinnitus, Subjective
Not applicableNot yet recruitingUniversity of Zurich242027-01-012026-09-21
Efficacy of Acupuncture on Chronic Tinnitus and Its Association With Auditory Brainstem Response Measures
Acupuncture - Tinnitus, Acupuncture
Not applicableNot yet recruitingThe Third Affiliated hospital of Zhejiang Chinese Medical University722026-12-312026-04-13
Verification of the Efficacy/Safety of the Mixed Drug Injectable Delivery Vehicle for Treating Intractable Hearing Loss
Dexamethasone, Hyaluronic acid, Indocyanine green(ICG) - Hearing Loss, Sensorineural, Hearing Loss, Sudden
Phase 1 / Phase 2WithdrawnSeoul National University Hospital2026-12-152026-05-22
24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
N-acetylcysteine amide, Placebo - Retinitis Pigmentosa (RP), Usher Syndrome
Phase 3Not yet recruitingNacuity Pharmaceuticals, Inc.802026-12-012026-07-01
SPI-1005 in Adults Receiving Cochlear Implant
Ebselen, Placebo - Hearing Loss, Cochlear Trauma
Phase 2RecruitingSound Pharmaceuticals, Incorporated402026-12-012026-06-26
HEARS Maryland: Extending Capacity for Affordable, Accessible Hearing Care Through Older Adult Peer Mentorship
HEARS MD Device, HEARS MD Program - Hearing Loss, Hearing Impairment
Not applicableNot yet recruitingJohns Hopkins University3002026-11-302026-07-29
Emerging Indications for Hyperbaric Oxygen Treatment
Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis
Phase 4Not yet recruitingJay C. Buckey Jr.1002026-11-012026-09-09

Showing 20 of 1763. Sign in to see all of them.

Narrower conditions

Hearing Loss (764)  ·  Tinnitus (426)  ·  Hearing Loss, Sensorineural (336)  ·  Deafness (148)  ·  Hearing Loss, Conductive (81)  ·  Presbycusis (66)  ·  Hearing Loss, Sudden (65)  ·  Hearing Loss, Bilateral (54)  ·  Hearing Loss, Unilateral (49)  ·  Hearing Loss, Noise-Induced (45)  ·  Hearing Loss, Mixed Conductive-Sensorineural (43)  ·  Cognitive Dysfunction (34)  ·  Usher Syndromes (33)  ·  Hyperacusis (32)

Broader conditions

Nervous System Diseases (1760)  ·  Neurologic Manifestations (1759)  ·  Sensation Disorders (1756)  ·  Pathological Conditions, Signs and Symptoms (1754)  ·  Signs and Symptoms (1752)  ·  Otorhinolaryngologic Diseases (1744)  ·  Ear Diseases (1741)  ·  Hearing Loss (597)  ·  Hearing Loss, Sensorineural (125)  ·  Mental Disorders (100)  ·  Eye Diseases (93)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (87)  ·  Behavior (85)  ·  Central Nervous System Diseases (75)

Interventions

Hearing Aids (79)  ·  Cochlear Implants (45)  ·  Transcranial Direct Current Stimulation (22)  ·  Cochlear Implantation (19)  ·  Cognitive Behavioral Therapy (14)  ·  Transcranial Magnetic Stimulation (14)  ·  Audiometry (13)  ·  Dexamethasone (13)  ·  Hearing (12)  ·  Acetylcysteine (11)  ·  ebselen (11)  ·  Surveys and Questionnaires (10)  ·  Noise (9)  ·  Acupuncture Therapy (8)  ·  Counseling (8)

Sponsors

Cochlear (83)  ·  Sonova AG (81)  ·  Oticon Medical (43)  ·  Washington University School of Medicine (31)  ·  VA Office of Research and Development (25)  ·  MED-EL Elektromedizinische Geräte GesmbH (24)  ·  Assistance Publique - Hôpitaux de Paris (23)  ·  US Department of Veterans Affairs (22)  ·  University Hospital, Antwerp (21)  ·  Eye & ENT Hospital of Fudan University (19)  ·  Northwestern University (18)  ·  Med-El Corporation (16)  ·  NYU Langone Health (16)  ·  University Hospital, Toulouse (16)  ·  Assiut University (14)

Countries

United States (642)  ·  France (173)  ·  United Kingdom (99)  ·  Germany (96)  ·  Switzerland (74)  ·  Belgium (72)  ·  Canada (70)  ·  China (68)  ·  Australia (62)  ·  Netherlands (49)  ·  Turkey (Türkiye) (46)  ·  Brazil (33)  ·  Sweden (30)  ·  Spain (29)  ·  Denmark (28)

Top investigators

Jinyu Qian, PhD (9)  ·  Jay F Piccirillo, MD (8)  ·  Carl LeBel, PhD (7)  ·  Jonathan Kil, MD (6)  ·  Barbara Simon, AuD (5)  ·  Bart Volckaerts, PhD (5)  ·  Juliane Raether (5)  ·  Ali Ismail, lecturer (4)  ·  Pamela Souza, PhD (4)  ·  Shan Sun (4)  ·  Thomas B Friedman, Ph.D. (4)  ·  Yu-Hsiang Wu, PhD (4)  ·  Berthold Langguth (3)  ·  Berthold Langguth, MD (3)

Results publications

PMID 35724253, PMID 17030153, PMID 22633033, PMID 24975234, PMID 25133431, PMID 27592038, PMID 29330858, PMID 29655489, PMID 30300158, PMID 31830753, PMID 32483557, PMID 34417217, PMID 35386404, PMID 35998103, PMID 36907833, PMID 37287104, PMID 37318215, PMID 37552281, PMID 41059917, PMID 41085057, PMID 10459293, PMID 10547481, PMID 10590970, PMID 11074842, PMID 11283492, PMID 11587599, PMID 11893444, PMID 12238249, PMID 12467365, PMID 12467367, PMID 12697801, PMID 12697802, PMID 12809326, PMID 12851547, PMID 14518792, PMID 14576249, PMID 15064663, PMID 15189754, PMID 15341225, PMID 15474106, PMID 1555319, PMID 15715067, PMID 15903144, PMID 15978485, PMID 16244757, PMID 16244758, PMID 16244759, PMID 16353397, PMID 16504089, PMID 16640056

NIH funding

R01DC015997 (4), 2018 (3), 2023 (3), 2009 (2), 2025 (2), K23DC022303 (2), R01DC012289 (2), R01DC020194 (2), R01DC021980 (2), R33DC011827 (2), U01HG006487 (2), 1IK2RX003281-01A2 (1), 1KL2TR002646-01 (1), 1RC1LM010526 (1), 1RF1MH114244 (1)